A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
Apolipoprotein E Genotyping, Blood
MessageAPOE genotypting has been used to assess susceptibility for Alzheimer disease. However, the use of APOE analysis for predictive testing for Alzheimer disease is not currently recommended by the American College of Medical Genetics due to limited clinical utility and poor predictive value.
Test Code
APOAR
Alias/See Also
APOE, Dislipidemia, Dysbetalipoproteinemia, Dyslipidemia, Dyslipoproteinemia, Alzheimer disease, Dementia, Frederickson Type III, Hyperlipidemia Type III, Type III hyperlipoproteinemia
CPT Codes
81401
Physician Attestation of Informed Consent
See Additional Information below for the Informed Consent for Genetic Testing form.
Includes
Result Summary, Result, Interpretation, Reason for Referral, Specimen, Source, Released By
Preferred Specimen
3 mL Lavender (EDTA) whole blood
Minimum Volume
1 mL
Other Acceptable Specimens
Yellow top (ACD), Sodium Heparin whole blood, Sodium Citrate whole blood
Instructions
Invert specimen several time to mix blood. Send whole blood specimen in original tube. Do not aliquot.
Transport Temperature
Room temperature
Specimen Stability
Specimen preferred to arrive within 96 hours of collection
Reject Criteria (Eg, hemolysis? Lipemia? Thaw/Other?)
All specimens will be evaluated at Mayo Clinic Laboratories for test suitability.
Methodology
PCR including Restriction Digest
FDA Status
LDT
Setup Schedule
Wednesday
Report Available
9-10 days
Reference Range
An interpretive report will be provided.
Clinical Significance
Determining the specific apolipoprotein E (APOE) genotypes in patients with type III hyperlipoproteinemia.
Performed By
Alverno Laboratories
Performing Laboratory
Mayo Clinic Laboratories
Test Code: APOEG
Last Updated: August 2, 2024